Anlon Healthcare Limited Approves Acquisition to Transform into Complete Pharmaceutical Provider

Anlon Healthcare Limited Approves Acquisition to Transform into Complete Pharmaceutical Provider​

Anlon Healthcare Limited has announced that its Board of Directors approved the acquisition of a substantial stake in Remember India Health Links Private Limited. The transaction is set to significantly enhance Anlon’s presence across the pharmaceutical value chain, transforming the company from a B2B ingredient supplier into a comprehensive pharmaceutical and healthcare platform.

On April 16, 2026, the Board approved the acquisition of 1,11,00,000 Equity Shares, representing 63.98% of the Equity Share Capital of Remember India Health Links Private Limited. The acquisition is being executed for a consideration amount of Rs. 5,38,12,800.

The shares will be acquired from certain existing shareholders of the Target Company, based on the terms and conditions outlined in the share purchase agreement dated April 16, 2026. Upon the completion of this acquisition, Remember India Health Links Private Limited is expected to become a subsidiary of Anlon Healthcare Limited.

Strategic Expansion in Pharmaceuticals​

The primary objective of the acquisition is to facilitate Anlon’s transition from solely an API (Active Pharmaceutical Ingredients) manufacturer to a complete pharmaceutical provider. Through this strategic move, Anlon plans to expand its market reach by moving beyond drug substances into finished dosage formulations (FDFs). Furthermore, the acquisition provides access to more than 30 dossiers related to finished dosage formulations.

The company stated that the impact of the proposed acquisition is anticipated across operational, financial, and regulatory dimensions. It is expected to facilitate the integration of quality control processes, strengthen Anlon's financial profile, and enhance its market positioning in both domestic and international retail and hospital markets.

Details of the Acquired Entity​

Remember India Health Links Private Limited is an Indian private limited company, incorporated on December 17, 2020. The Target Company is engaged in the business of manufacturing, processing, producing, packing, selling, blending, making, and dealing in various kinds and varieties of pharmaceutical finished products, including tablets and capsules.

The key details and historical financial performance of the Target Company are summarized below:


The Target Company's turnover over the last three financial years was:


The proposed acquisition is subject to the completion of certain condition precedents under the share purchase agreement and is expected to be completed at the earliest, but within 4 to 5 months from the date of signing the agreement, or by other mutually agreed timelines. The consideration for the shares will be paid in cash.

AHCL Stock Price Movement​

As of 1:15 PM, shares of Anlon Healthcare Limited are edging higher today, gaining 1.22% and currently trading at ₹140.48. The momentum saw significant activity, occurring on a total traded volume of 299,756 shares.

Source:​